Skip to main content

and
  1. Article

    Open Access

    Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort study

    To evaluate immune responses to COVID-19 vaccines in adults aged 50 years and older, spike protein (S)-specific antibody concentration, avidity, and function (via angiotensin-converting enzyme 2 (ACE2) inhibit...

    Gabrielle N. Gaultier, Brynn McMillan, Chad Poloni, Mandy Lo in Scientific Reports (2024)

  2. Article

    Open Access

    Uptake of SARS-CoV-2 vaccination among structurally-marginalized people who use drugs in Vancouver, Canada

    We sought to evaluate the rates and predictors of SARS-CoV-2 vaccination among members of a structurally-marginalized population of people who use drugs (PWUD) during a targeted, community-wide, vaccination ca...

    Hudson Reddon, Brittany Barker, Sofia Bartlett, Ana Citlali Márquez in Scientific Reports (2023)

  3. Article

    Open Access

    Hepatitis C cross-genotype immunity and implications for vaccine development

    While about a quarter of individuals clear their primary hepatitis C (HCV) infections spontaneously, clearance (spontaneous or treatment-induced) does not confer sterilizing immunity against a future infection...

    Nazrul Islam, Mel Krajden, Jean Shoveller, Paul Gustafson in Scientific Reports (2017)